U.S. Food et al., 2017-11-21: FDA page stating that DIY gene-therapy kits for self-administration are being sold to the public, that their sale is against the law, and that any human use of CRISPR/Cas9 is gene therapy; clinical studies require an IND and marketing requires a BLA.
The sale of these products is against the law.
Body (page states 'Content current as of: 11/21/2017')
U.S. Food et al., 2017-11-21: FDA page stating that DIY gene-therapy kits for self-administration are being sold to the public, that their sale is against the law, and that any human use of CRISPR/Cas9 is gene therapy; clinical studies require an IND and marketing requires a BLA. This is the agency's November 2017 position the claim refers to; the page is dated 11/21/2017 at its foot. No PDF edition. The excerpt is the shortest sentence carrying the legal position; the preceding sentence names 'do it yourself' kits. No funder/COI. Study type: regulatory record.
